Divi's Laboratories Ltd. - Research Center
532488 DIVISLAB Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 4,365.00 | 3,598.00 | 4,027.30 | 4,961.80 | 3,918.02 |
| Operating profit | 1,351.00 | 965.00 | 1,446.84 | 2,195.87 | 1,676.97 |
| Interest | 1.00 | 1.00 | 0.23 | 0.24 | 0.41 |
| Gross profit | 1,533.00 | 1,129.00 | 1,615.85 | 2,262.76 | 1,724.31 |
| EPS (Rs) | 35.77 | 25.92 | 44.39 | 67.44 | 43.64 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 183.00 | 165.00 | 169.24 | 67.13 | 47.75 |
| Stock adjustment | -55.00 | -54.00 | -123.72 | -118.61 | -331.38 |
| Raw material | 1,835.00 | 1,529.00 | 1,590.24 | 1,813.51 | 1,626.28 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 581.00 | 516.00 | 468.27 | 491.21 | 435.34 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 653.00 | 642.00 | 645.67 | 579.82 | 510.81 |
| Provisions made | - | - | - | - | - |
| Depreciation | 195.00 | 187.00 | 168.90 | 160.45 | 150.10 |
| Taxation | 390.00 | 255.00 | 268.49 | 312.13 | 415.85 |
| Net profit / loss | 948.00 | 687.00 | 1,178.46 | 1,790.18 | 1,158.36 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 53.00 | 53.00 | 53.09 | 53.09 | 53.09 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 30.95 | 26.82 | 35.93 | 44.26 | 42.80 |
| GPM (%) | 33.71 | 30.00 | 38.50 | 44.99 | 43.48 |
| NPM (%) | 20.84 | 18.26 | 28.08 | 35.60 | 29.21 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis